Sleep aids registered relatively limited current value growth of 2% in 2016 as retail volume sales in the category saw a marginal decline. According to the National Health Insurance Service, around 459,000 people visited medical clinics or hospitals with sleeping disorders in 2015, which is an increase of 58% from the 289,500 registered in 2010. It is also estimated by trade press that four million people have insomnia caused by stress, and this reached to up 12% of the adult population in 2015.
Euromonitor International's Sleep Aids in South Korea report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Get a detailed picture of the Sleep Aids market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market’s major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.